Transcription Factors
暂无分享,去创建一个
[1] J. Ihle. The Stat family in cytokine signaling. , 2001, Current opinion in cell biology.
[2] D. Levy,et al. Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease , 1996, Cell.
[3] Yuichi Makino,et al. Regulation of the Hypoxia-inducible Transcription Factor 1α by the Ubiquitin-Proteasome Pathway* , 1999, The Journal of Biological Chemistry.
[4] B. Chait,et al. DNA binding of in vitro activated Stat1 alpha, Stat1 beta and truncated Stat1: interaction between NH2‐terminal domains stabilizes binding of two dimers to tandem DNA sites. , 1996, The EMBO journal.
[5] J. Gutkind,et al. MAPK and Akt act cooperatively but independently on hypoxia inducible factor-1alpha in rasV12 upregulation of VEGF. , 2001, Biochemical and biophysical research communications.
[6] S. John,et al. Regulation of STAT signalling by proteolytic processing. , 2004, European journal of biochemistry.
[7] U. Vinkemeier,et al. Nucleocytoplasmic translocation of Stat1 is regulated by a leucine-rich export signal in the coiled-coil domain. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[8] R. Schreiber,et al. Stat recruitment by tyrosine-phosphorylated cytokine receptors: an ordered reversible affinity-driven process. , 1995, Immunity.
[9] B. Brüne,et al. HIF‐1α protein as a target for S‐nitrosation , 2003, FEBS letters.
[10] Edward Yang,et al. Dissociation Time from DNA Determines Transcriptional Function in a STAT1 Linker Mutant* , 2002, The Journal of Biological Chemistry.
[11] L. Kinnunen,et al. Arginine/Lysine-rich Nuclear Localization Signals Mediate Interactions between Dimeric STATs and Importin α5* , 2002, The Journal of Biological Chemistry.
[12] J. Darnell,et al. Crystal Structure of a Tyrosine Phosphorylated STAT-1 Dimer Bound to DNA , 1998, Cell.
[13] J. Darnell. STATs and gene regulation. , 1997, Science.
[14] E. Yang,et al. Modulation of p300 binding by posttranslational modifications of the C‐terminal activation domain of hypoxia‐inducible factor‐1α , 2007, FEBS letters.
[15] M. Ashcroft,et al. Growth Factor-Mediated Induction of HDM2 Positively Regulates Hypoxia-Inducible Factor 1α Expression , 2004, Molecular and Cellular Biology.
[16] J. Pouysségur,et al. Arrest-defective-1 Protein, an Acetyltransferase, Does Not Alter Stability of Hypoxia-inducible Factor (HIF)-1α and Is Not Induced by Hypoxia or HIF* , 2005, Journal of Biological Chemistry.
[17] D. Newmeyer,et al. Inhibition of in vitro nuclear transport by a lectin that binds to nuclear pores , 1987, The Journal of cell biology.
[18] H. Hauser,et al. Dynamic redistribution of STAT1 protein in IFN signaling visualized by GFP fusion proteins. , 1999, European journal of biochemistry.
[19] J. Darnell,et al. Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions , 1994, Cell.
[20] T. Kietzmann,et al. Induction of plasminogen activator inhibitor I gene expression by intracellular calcium via hypoxia-inducible factor-1. , 2004, Blood.
[21] Michael I. Wilson,et al. Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation , 2001, Science.
[22] C. Wykoff,et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.
[23] K. Kivirikko,et al. Posttranslational enzymes in the biosynthesis of collagen: intracellular enzymes. , 1982, Methods in enzymology.
[24] D. Peet,et al. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. , 2002, Genes & development.
[25] N. Sang,et al. MAPK Signaling Up-regulates the Activity of Hypoxia-inducible Factors by Its Effects on p300* , 2003, The Journal of Biological Chemistry.
[26] M. Yanagida,et al. Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. , 1998, Experimental cell research.
[27] E. Hur,et al. Mitogen-activated protein kinase kinase inhibitor PD98059 blocks the trans-activation but not the stabilization or DNA binding ability of hypoxia-inducible factor-1alpha. , 2001 .
[28] S. Adam,et al. Nuclear protein import in permeabilized mammalian cells requires soluble cytoplasmic factors , 1990, The Journal of cell biology.
[29] K. Kivirikko,et al. An Endoplasmic Reticulum Transmembrane Prolyl 4-Hydroxylase Is Induced by Hypoxia and Acts on Hypoxia-inducible Factor α* , 2007, Journal of Biological Chemistry.
[30] K. Kivirikko,et al. The Length of Peptide Substrates Has a Marked Effect on Hydroxylation by the Hypoxia-inducible Factor Prolyl 4-Hydroxylases* , 2006, Journal of Biological Chemistry.
[31] J. Darnell,et al. Signalling: STATs: transcriptional control and biological impact , 2002, Nature Reviews Molecular Cell Biology.
[32] I. Kerr,et al. STAT1 from the cell membrane to the DNA , 2001, The EMBO journal.
[33] J. Caro,et al. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. , 1997, The Journal of biological chemistry.
[34] M. Ivan,et al. Structure of an HIF-1α-pVHL Complex: Hydroxyproline Recognition in Signaling , 2002, Science.
[35] Christine C. Hudson,et al. Regulation of Hypoxia-Inducible Factor 1α Expression and Function by the Mammalian Target of Rapamycin , 2002, Molecular and Cellular Biology.
[36] R. Evjenth,et al. Interaction between HIF-1 alpha (ODD) and hARD1 does not induce acetylation and destabilization of HIF-1 alpha. , 2005, FEBS letters.
[37] B. Brüne,et al. Regulation of the hypoxia-inducible factor 1alpha by the inflammatory mediators nitric oxide and tumor necrosis factor-alpha in contrast to desferroxamine and phenylarsine oxide. , 2001, The Journal of biological chemistry.
[38] Hansjörg Hauser,et al. Nucleocytoplasmic shuttling revealed by FRAP and FLIP technologies. , 2005, Current opinion in biotechnology.
[39] G. Semenza,et al. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. , 2000, Cancer research.
[40] J E Darnell,et al. A nuclear protein tyrosine phosphatase is required for the inactivation of Stat1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[41] U. Vinkemeier,et al. Green fluorescent protein‐tagging reduces the nucleocytoplasmic shuttling specifically of unphosphorylated STAT1 , 2007, The FEBS journal.
[42] D. Mottet,et al. Regulation of Hypoxia-inducible Factor-1α Protein Level during Hypoxic Conditions by the Phosphatidylinositol 3-Kinase/Akt/Glycogen Synthase Kinase 3β Pathway in HepG2 Cells* , 2003, Journal of Biological Chemistry.
[43] Y. M. Lee,et al. Jab1 interacts directly with HIF-1alpha and regulates its stability. , 2002, The Journal of biological chemistry.
[44] G. Semenza. Signal transduction to hypoxia-inducible factor 1. , 2002, Biochemical pharmacology.
[45] T. Decker,et al. GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. , 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[46] F. Holsboer,et al. RSUME, a Small RWD-Containing Protein, Enhances SUMO Conjugation and Stabilizes HIF-1α during Hypoxia , 2007, Cell.
[47] Yu-Rong Fu,et al. Identification of a Nuclear Stat 1 Protein Tyrosine Phosphatase , 2002 .
[48] U. Vinkemeier,et al. A Single Residue Modulates Tyrosine Dephosphorylation, Oligomerization, and Nuclear Accumulation of Stat Transcription Factors* , 2004, Journal of Biological Chemistry.
[49] J. Darnell,et al. Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein. , 1992, Science.
[50] P. Sehgal. Paradigm shifts in the cell biology of STAT signaling. , 2008, Seminars in cell & developmental biology.
[51] Andreas Marg,et al. DNA binding controls inactivation and nuclear accumulation of the transcription factor Stat1. , 2003, Genes & development.
[52] I. Lödige,et al. Constitutive and IFN‐γ‐induced nuclear import of STAT1 proceed through independent pathways , 2002 .
[53] J. Darnell,et al. Maximal activation of transcription by statl and stat3 requires both tyrosine and serine phosphorylation , 1995, Cell.
[54] E. Cummins,et al. c-Jun NH2-Terminal Kinase Activation Contributes to Hypoxia-Inducible Factor 1α–Dependent P-Glycoprotein Expression in Hypoxia , 2004, Cancer Research.
[55] R. Schreiber,et al. Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling Pathway , 1996, Cell.
[56] M. Dewhirst,et al. Regulation of HIF-1alpha stability through S-nitrosylation. , 2007, Molecular cell.
[57] G. Semenza,et al. FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. , 2001 .
[58] J. Pouysségur,et al. p42/p44 Mitogen-activated Protein Kinases Phosphorylate Hypoxia-inducible Factor 1α (HIF-1α) and Enhance the Transcriptional Activity of HIF-1* , 1999, The Journal of Biological Chemistry.
[59] A. Koong,et al. Loss of PTEN facilitates HIF-1-mediated gene expression. , 2000, Genes & development.
[60] Jinke Cheng,et al. SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. , 2007, Cell.
[61] Christopher J Schofield,et al. Hypoxia-inducible Factor (HIF) Asparagine Hydroxylase Is Identical to Factor Inhibiting HIF (FIH) and Is Related to the Cupin Structural Family* , 2002, The Journal of Biological Chemistry.
[62] T. Hoey,et al. Cooperative DNA Binding and Sequence-Selective Recognition Conferred by the STAT Amino-Terminal Domain , 1996, Science.
[63] J. Pouysségur,et al. ARDent about acetylation and deacetylation in hypoxia signalling. , 2006, Trends in cell biology.
[64] E. J. Song,et al. Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. , 2002, Cell.
[65] M. Vigneron,et al. Microinjected antibodies interfere with protein nucleocytoplasmic shuttling by distinct molecular mechanisms , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[66] G. Stark,et al. Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon‐alpha and ‐gamma signal transduction pathways. , 1993, The EMBO journal.
[67] J. Darnell,et al. Dephosphorylation of phosphotyrosine on STAT1 dimers requires extensive spatial reorientation of the monomers facilitated by the N-terminal domain. , 2006, Genes & development.
[68] S. Herzig,et al. Transcriptional regulation of plasminogen activator inhibitor-1 expression by insulin-like growth factor-1 via MAP kinases and hypoxia-inducible factor-1 in HepG2 cells , 2005, Thrombosis and Haemostasis.
[69] J. Darnell,et al. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.
[70] K. Jungermann,et al. Regulation of the hypoxia-dependent plasminogen activator inhibitor 1 expression by MAP kinases , 2003, Thrombosis and Haemostasis.
[71] A. Tee,et al. Hypoxia-inducible Factor 1α Is Regulated by the Mammalian Target of Rapamycin (mTOR) via an mTOR Signaling Motif* , 2007, Journal of Biological Chemistry.
[72] L. Poellinger,et al. Mechanism of regulation of the hypoxia‐inducible factor‐1α by the von Hippel‐Lindau tumor suppressor protein , 2000, The EMBO journal.
[73] J. Gordon. Use of vanadate as protein-phosphotyrosine phosphatase inhibitor. , 1991, Methods in enzymology.
[74] J. Fandrey,et al. Nitric Oxide Modulates Oxygen Sensing by Hypoxia-inducible Factor 1-dependent Induction of Prolyl Hydroxylase 2* , 2007, Journal of Biological Chemistry.
[75] J. Bromberg,et al. STAT proteins: signal tranducers and activators of transcription. , 2001, Methods in enzymology.
[76] G. Panayotou,et al. Identification of MAPK Phosphorylation Sites and Their Role in the Localization and Activity of Hypoxia-inducible Factor-1α* , 2006, Journal of Biological Chemistry.
[77] A. Brivanlou,et al. Signal Transduction and the Control of Gene Expression , 2002, Science.
[78] U. Vinkemeier,et al. Ratjadone and leptomycin B block CRM1‐dependent nuclear export by identical mechanisms , 2004, FEBS letters.
[79] Andreas Marg,et al. Nucleocytoplasmic shuttling by nucleoporins Nup153 and Nup214 and CRM1-dependent nuclear export control the subcellular distribution of latent Stat1 , 2004, The Journal of cell biology.
[80] Kyu-Won Kim,et al. Sumoylation increases HIF-1alpha stability and its transcriptional activity. , 2004, Biochemical and biophysical research communications.
[81] W. Webb,et al. Mobility measurement by analysis of fluorescence photobleaching recovery kinetics. , 1976, Biophysical journal.
[82] J. Darnell,et al. A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. , 1995, Genes & development.
[83] J. Darnell,et al. The rapid inactivation of nuclear tyrosine phosphorylated Stat1 depends upon a protein tyrosine phosphatase. , 1996, The EMBO journal.
[84] Kevin M. McBride,et al. Regulated nuclear import of the STAT1 transcription factor by direct binding of importin‐α , 2002, The EMBO journal.
[85] E. Paraskeva,et al. Atypical CRM1-dependent Nuclear Export Signal Mediates Regulation of Hypoxia-inducible Factor-1α by MAPK* , 2008, Journal of Biological Chemistry.
[86] R. Corriveau,et al. An Evolutionarily Conserved N-terminal Acetyltransferase Complex Associated with Neuronal Development* , 2003, Journal of Biological Chemistry.
[87] R. Johns,et al. Normoxic stabilization of hypoxia-inducible factor-1 expression and activity: redox-dependent effect of nitrogen oxides. , 2000, Molecular pharmacology.
[88] B. Brüne,et al. Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases. , 2003, Molecular biology of the cell.
[89] M. Ivan,et al. Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel–Lindau protein , 2000, Nature Cell Biology.
[90] T. Hunter,et al. Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. , 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[91] P. Bucher,et al. DNA Binding Specificity of Different STAT Proteins , 2001, The Journal of Biological Chemistry.
[92] G. Semenza,et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. , 2000, Genes & development.
[93] Denis Mottet,et al. Transduction pathways involved in Hypoxia-Inducible Factor-1 phosphorylation and activation. , 2001, Free radical biology & medicine.
[94] J. Darnell,et al. Interactions between STAT and non-STAT proteins in the interferon-stimulated gene factor 3 transcription complex , 1996, Molecular and cellular biology.
[95] J. Darnell,et al. A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. , 1993, Science.
[96] D. Peet,et al. Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch , 2002, Science.
[97] K. Baringhaus,et al. Inhibition of prolyl 4-hydroxylase by oxalyl amino acid derivatives in vitro, in isolated microsomes and in embryonic chicken tissues. , 1994, The Biochemical journal.
[98] P. Ratcliffe,et al. Independent function of two destruction domains in hypoxia‐inducible factor‐α chains activated by prolyl hydroxylation , 2001, The EMBO journal.
[99] M. Tremblay,et al. The T-cell protein tyrosine phosphatase. , 2000, Seminars in immunology.
[100] J. Pouysségur,et al. SUMOylation of hypoxia-inducible factor-1alpha reduces its transcriptional activity. , 2007, Biochemical and biophysical research communications.
[101] J. Darnell,et al. Implications of an antiparallel dimeric structure of nonphosphorylated STAT1 for the activation-inactivation cycle. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[102] T. Kietzmann,et al. Glycogen Synthase Kinase 3 Phosphorylates Hypoxia-Inducible Factor 1α and Mediates Its Destabilization in a VHL-Independent Manner , 2007, Molecular and Cellular Biology.